Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism

Cell

Volumn 145, Issue 1, 2011, Pages 39-53

  Adams, Kristin N ^a   Takaki, Kevin ^a   Connolly, Lynn E ^a   Wiedenhoft, Heather ^a   Winglee, Kathryn ^a   Humbert, Olivier ^a   Edelstein, Paul H ^b   Cosma, Christine L ^a   Ramakrishnan, Lalita ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; RIFAMPICIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIVISION; CELL POPULATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TOLERANCE; FLUORESCENCE MICROSCOPY; GRANULOMA; IN VIVO STUDY; LARVA; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; ZEBRA FISH;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; DANIO RERIO; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 79953279193     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2011.02.022     Document Type: Article

References (67)

1. M. Akira, M. Sakatani, and H. Ishikawa Transient radiographic progression during initial treatment of pulmonary tuberculosis: CT findings J. Comput. Assist. Tomogr. 24 2000 426 431 (Pubitemid 32203936)
2. L. Amaral, M. Martins, and M. Viveiros Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps J. Antimicrob. Chemother. 59 2007 1237 1246 (Pubitemid 47073342)
3. A. Aubry, O. Chosidow, E. Caumes, J. Robert, and E. Cambau Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates Arch. Intern. Med. 162 2002 1746 1752
4. J. Barker, H. Scaife, and M.R. Brown Intraphagocytic growth induces an antibiotic-resistant phenotype of Legionella pneumophila Antimicrob. Agents Chemother. 39 1995 2684 2688
5. C.E. Barry III, H.I. Boshoff, V. Dartois, T. Dick, S. Ehrt, J. Flynn, D. Schnappinger, R.J. Wilkinson, and D. Young The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Nat. Rev. Microbiol. 7 2009 845 855
6. A.E. Belanger, G.S. Besra, M.E. Ford, K. Mikusová, J.T. Belisle, P.J. Brennan, and J.M. Inamine The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol Proc. Natl. Acad. Sci. USA 93 1996 11919 11924 (Pubitemid 26347224)
7. I.D. Bobrowitz Reversible roentgenographic progression in the initial treatment of pulmonary tuberculosis Am. Rev. Respir. Dis. 121 1980 735 742 (Pubitemid 10150588)
8. G. Canetti The Tubercle Bacillus in the Pulmonary Lesion of Man; Histobacteriology and Its Bearing on the Therapy of Pulmonary Tuberculosis 1955 Springer New York
9. H. Clay, J.M. Davis, D. Beery, A. Huttenlocher, S.E. Lyons, and L. Ramakrishnan Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish Cell Host Microbe 2 2007 29 39 (Pubitemid 47010243)
10. R. Colangeli, D. Helb, S. Sridharan, J. Sun, M. Varma-Basil, M.H. Hazbón, R. Harbacheuski, N.J. Megjugorac, W.R. Jacobs Jr.; and A. Holzenburg The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol Mol. Microbiol. 55 2005 1829 1840 (Pubitemid 40445216)
11. L.E. Connolly, P.H. Edelstein, and L. Ramakrishnan Why is long-term therapy required to cure tuberculosis? PLoS Med. 4 2007 e120
12. C.L. Cosma, O. Humbert, and L. Ramakrishnan Superinfecting mycobacteria home to established tuberculous granulomas Nat. Immunol. 5 2004 828 835 (Pubitemid 39172976)
13. C.L. Cosma, J.M. Davis, L.E. Swaim, H. Volkman, and L. Ramakrishnan Zebrafish and Frog Models of Mycobacterium marinum Infection R. Coico, T. Kowalik, J. Quarles, B. Stevenson, R. Taylor, Current Protocols in Microbiology 2006 John Wiley and Sons New York
14. C.L. Cosma, K. Klein, R. Kim, D. Beery, and L. Ramakrishnan Mycobacterium marinum Erp is a virulence determinant required for cell wall integrity and intracellular survival Infect. Immun. 74 2006 3125 3133 (Pubitemid 43794501)
15. A.M. Dannenberg Jr. Macrophage turnover, division and activation within developing, peak and "healed" tuberculous lesions produced in rabbits by BCG Tuberculosis (Edinb.) 83 2003 251 260 (Pubitemid 36995247)
16. J.M. Davis, and L. Ramakrishnan The role of the granuloma in expansion and dissemination of early tuberculous infection Cell 136 2009 37 49
17. E. De Rossi, J.A. Aínsa, and G. Riccardi Role of mycobacterial efflux transporters in drug resistance: an unresolved question FEMS Microbiol. Rev. 30 2006 36 52
18. A. Decostere, K. Hermans, and F. Haesebrouck Piscine mycobacteriosis: a literature review covering the agent and the disease it causes in fish and humans Vet. Microbiol. 99 2004 159 166 (Pubitemid 38471649)
19. J.E. de Steenwinkel, G.J. de Knegt, M.T. Ten Kate, A. van Belkum, H.A. Verbrugh, K. Kremer, D. van Soolingen, and I.A. Bakker-Woudenberg Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis J. Antimicrob. Chemother. 65 2010 2582 2589
20. P.R. Donald, and A.H. Diacon The early bactericidal activity of anti-tuberculosis drugs: a literature review Tuberculosis (Edinb.) 88 Suppl 1 2008 S75 S83
21. P.R. Donald, and H. McIlleron Antituberculosis drugs H. Schaaf, A. Zumla, Tuberculosis: A Comprehensive Clinical Reference 2009 Saunders Elsevier London, UK 608 617
22. L.A. Duits, M. Rademaker, B. Ravensbergen, M.A. van Sterkenburg, E. van Strijen, P.S. Hiemstra, and P.H. Nibbering Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids Biochem. Biophys. Res. Commun. 280 2001 522 525 (Pubitemid 32912822)
23. J. Ehrchen, L. Steinmüller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkötter, and J. Roth Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes Blood 109 2007 1265 1274 (Pubitemid 46220679)
24. P.A. Fontán, V. Aris, M.E. Alvarez, S. Ghanny, J. Cheng, P. Soteropoulos, A. Trevani, R. Pine, and I. Smith Mycobacterium tuberculosis sigma factor E regulon modulates the host inflammatory response J. Infect. Dis. 198 2008 877 885
25. N.J. Garton, S.J. Waddell, A.L. Sherratt, S.M. Lee, R.J. Smith, C. Senner, J. Hinds, K. Rajakumar, R.A. Adegbola, and G.S. Besra Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum PLoS Med. 5 2008 e75
26. W.P. Gill, N.S. Harik, M.R. Whiddon, R.P. Liao, J.E. Mittler, and D.R. Sherman A replication clock for Mycobacterium tuberculosis Nat. Med. 15 2009 211 214
27. A.K. Gupta, V.M. Katoch, D.S. Chauhan, R. Sharma, M. Singh, K. Venkatesan, and V.D. Sharma Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs Microb. Drug Resist. 16 2010 21 28
28. M. Ibrahim, C. Truffot-Pernot, K. Andries, V. Jarlier, and N. Veziris Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis Am. J. Respir. Crit. Care Med. 180 2009 553 557
29. A. Jindani, C.J. Doré, and D.A. Mitchison Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days Am. J. Respir. Crit. Care Med. 167 2003 1348 1354 (Pubitemid 36609718)
30. M.A. Kohanski, D.J. Dwyer, and J.J. Collins How antibiotics kill bacteria: from targets to networks Nat. Rev. Microbiol. 8 2010 423 435
31. A. Koul, L. Vranckx, N. Dendouga, W. Balemans, I. Van den Wyngaert, K. Vergauwen, H.W. Göhlmann, R. Willebrords, A. Poncelet, and J. Guillemont Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis J. Biol. Chem. 283 2008 25273 25280
32. G. Lamichhane, M. Zignol, N.J. Blades, D.E. Geiman, A. Dougherty, J. Grosset, K.W. Broman, and W.R. Bishai A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis Proc. Natl. Acad. Sci. USA 100 2003 7213 7218 (Pubitemid 36706418)
33. X.Z. Li, and H. Nikaido Efflux-mediated drug resistance in bacteria: an update Drugs 69 2009 1555 1623
34. P.T. Liu, S. Stenger, D.H. Tang, and R.L. Modlin Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin J. Immunol. 179 2007 2060 2063
35. G.E. Louw, R.M. Warren, N.C. Gey van Pittius, C.R. McEvoy, P.D. Van Helden, and T.C. Victor A balancing act: efflux/influx in mycobacterial drug resistance Antimicrob. Agents Chemother. 53 2009 3181 3189
36. R.P. Morris, L. Nguyen, J. Gatfield, K. Visconti, K. Nguyen, D. Schnappinger, S. Ehrt, Y. Liu, L. Heifets, and J. Pieters Ancestral antibiotic resistance in Mycobacterium tuberculosis Proc. Natl. Acad. Sci. USA 102 2005 12200 12205 (Pubitemid 41291152)
37. G.V. Mukamolova, O. Turapov, J. Malkin, G. Woltmann, and M.R. Barer Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum Am. J. Respir. Crit. Care Med. 181 2010 174 180
38. E.J. Muñoz-Elías, J. Timm, T. Botha, W.T. Chan, J.E. Gomez, and J.D. McKinney Replication dynamics of Mycobacterium tuberculosis in chronically infected mice Infect. Immun. 73 2005 546 551 (Pubitemid 40041149)
39. L. Nguyen, and C.J. Thompson Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm Trends Microbiol. 14 2006 304 312 (Pubitemid 43963364)
40. C.N. Paramasivan, S. Sulochana, G. Kubendiran, P. Venkatesan, and D.A. Mitchison Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis Antimicrob. Agents Chemother. 49 2005 627 631 (Pubitemid 40175672)
41. S. Ramón-García, C. Martín, C.J. Thompson, and J.A. Aínsa Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth Antimicrob. Agents Chemother. 53 2009 3675 3682
42. A.R. Rich The Pathogenesis of Tuberculosis Second Edition 1946 Charles C. Thomas Springfield, IL
43. B. Rivas-Santiago, R. Hernandez-Pando, C. Carranza, E. Juarez, J.L. Contreras, D. Aguilar-Leon, M. Torres, and E. Sada Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells Infect. Immun. 76 2008 935 941 (Pubitemid 351428052)
44. K.H. Rohde, R.B. Abramovitch, and D.G. Russell Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues Cell Host Microbe 2 2007 352 364 (Pubitemid 350056395)
45. G.A. Rook, J. Steele, M. Ainsworth, and C. Leveton A direct effect of glucocorticoid hormones on the ability of human and murine macrophages to control the growth of M. tuberculosis Eur. J. Respir. Dis. 71 1987 286 291 (Pubitemid 18089672)
46. J.C. Sacchettini, E.J. Rubin, and J.S. Freundlich Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis Nat. Rev. Microbiol. 6 2008 41 52 (Pubitemid 350286219)
47. A. Sandgren, M. Strong, P. Muthukrishnan, B.K. Weiner, G.M. Church, and M.B. Murray Tuberculosis drug resistance mutation database PLoS Med. 6 2009 e2
48. D. Schnappinger, S. Ehrt, M.I. Voskuil, Y. Liu, J.A. Mangan, I.M. Monahan, G. Dolganov, B. Efron, P.D. Butcher, C. Nathan, and G.K. Schoolnik Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment J. Exp. Med. 198 2003 693 704 (Pubitemid 37087769)
49. S. Sharma, M. Kumar, S. Sharma, A. Nargotra, S. Koul, and I.A. Khan Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis J. Antimicrob. Chemother. 65 2010 1694 1701
50. N. Siddiqi, R. Das, N. Pathak, S. Banerjee, N. Ahmed, V.M. Katoch, and S.E. Hasnain Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump Infection 32 2004 109 111 (Pubitemid 38457104)
51. D.M. Tobin, and L. Ramakrishnan Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis Cell. Microbiol. 10 2008 1027 1039 (Pubitemid 351540503)
52. D.M. Tobin, J.C. Vary Jr.; J.P. Ray, G.S. Walsh, S.J. Dunstan, N.D. Bang, D.A. Hagge, S. Khadge, M.C. King, and T.R. Hawn The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans Cell 140 2010 717 730
53. Y.L. Tzeng, K.D. Ambrose, S. Zughaier, X. Zhou, Y.K. Miller, W.M. Shafer, and D.S. Stephens Cationic antimicrobial peptide resistance in Neisseria meningitidis J. Bacteriol. 187 2005 5387 5396 (Pubitemid 41022958)
54. M. Viveiros, I. Portugal, R. Bettencourt, T.C. Victor, A.M. Jordaan, C. Leandro, D. Ordway, and L. Amaral Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis Antimicrob. Agents Chemother. 46 2002 2804 2810
55. H.E. Volkman, H. Clay, D. Beery, J.C. Chang, D.R. Sherman, and L. Ramakrishnan Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant PLoS Biol. 2 2004 e367
56. H.E. Volkman, T.C. Pozos, J. Zheng, J.M. Davis, J.F. Rawls, and L. Ramakrishnan Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium Science 327 2010 466 469
57. D.F. Warner, and V. Mizrahi Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy Clin. Microbiol. Rev. 19 2006 558 570 (Pubitemid 44134310)
58. D. Zähner, X. Zhou, S.T. Chancey, J. Pohl, W.M. Shafer, and D.S. Stephens Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae Antimicrob. Agents Chemother. 54 2010 3516 3519
59. Burgos, J.S.; Ripoll-Gomez, J.; Alfaro, J.M.; Sastre, I.; and Valdivieso, F. (2008). Zebrafish as a new model for herpes simplex virus type 1 infection. Zebrafish 5, 323-333.
60. Conde, M.B.; Efron, A.; Loredo, C.; De Souza, G.R.; Graa, N.P.; Cezar, M.C.; Ram, M.; Chaudhary, M.A.; Bishai, W.R.; Kritski, A.L.; and Chaisson, R.E. (2009). Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 373, 1183-1189.
61. Dhar, N.; and McKinney, J.D. (2007). Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 10, 30-38. (Pubitemid 46216877)
62. Gillespie, S.H.; and Billington, O. (1999). Activity of moxifloxacin against mycobacteria. J. Antimicrob. Chemother. 44, 393-395. (Pubitemid 29425693)
63. Heifets, L. (1991). Drug susceptibility in the chemotherapy of mycobacterial infections (Boca Raton, FL: CRC Press).
64. Kremer, L.; Douglas, J.D.; Baulard, A.R.; Morehouse, C.; Guy, M.R.; Alland, D.; Dover, L.G.; Lakey, J.H.; Jacobs, W.R.; Jr.; Brennan, P.J.; et al. (2000). Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J. Biol. Chem. 275, 16857-16864. (Pubitemid 30398921)
65. Rastogi, N.; Goh, K.S.; Guillou, N.; and Labrousse, V. (1992). Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs? Zentralbl. Bakteriol. 277, 474-484.
66. Silcox, V.A.; and David, H.L. (1971). Differential identification of Mycobacterium kansasii and Mycobacterium marinum. Appl. Microbiol. 21, 327-334.
67. Warner, D.F.; and Mizrahi, V. (2006). Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy. Clin. Microbiol. Rev. 19, 558-570. (Pubitemid 44134310)